In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

LeukoSite and Roche Bioscience work on asthma and allergies

Executive Summary

LeukoSite (inflammatory and autoimmune diseases) and Roche Bioscience will collaborate to research and develop new treatments for asthma and allergic disorders based on LeukoSite's knowledge of eosinophil chemokine receptors.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing

Related Companies